A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Titel:: A single arm, multicentre, open-label phase II study of orally administered lapatinib (GW572016) as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
Dokumenttyp:: Meeting Abstract
Autor(en):: Grimm, MO; Machiels, JP; Wülfing, C; Richel, D; Treiber, U; de Groot, M; Beuzeboc, P; Farrell, J; Colman, J; El-Hariry, I
Zeitschriftentitel:: Ann Oncol
Jahr:: 2005
Band / Volume:: 16 Suppl.
Seitenangaben Beitrag:: 41-41
Sprache:: eng
Print-ISSN:: 0923-7534
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: